Dow Surges Over 300 Points Amid Mixed Market Performance
TL;DR Summary
The Dow Jones rose slightly while the S&P 500 and Nasdaq fell, with AI chip stocks like Nvidia continuing to decline. Biotech firm Sarepta Therapeutics surged 38% after FDA approval for its gene therapy. Microsoft saw a price target increase from Citigroup, while Palantir dropped 4% following a downgrade.
- Stock Market Today: Dow Jones Rises, S&P 500 Falls As Nvidia, AI Stocks Extend Losses; Sarepta Surges Investor's Business Daily
- Dow leads charge, S&P 500 and Nasdaq flat at open Yahoo Finance
- Salesforce, Chevron share gains lead Dow's nearly 225-point jump MarketWatch
- U.S. Markets Finished Mixed Thursday As Gilead Sciences Led, Jabil Lagged Barron's
- Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher By Benzinga Investing.com UK
Reading Insights
Total Reads
0
Unique Readers
10
Time Saved
4 min
vs 4 min read
Condensed
94%
758 → 49 words
Want the full story? Read the original article
Read on Investor's Business Daily